📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

IL-2 therapy preferentially expands adoptively transferred donor-specific Tregs improving skin allograft survival. (2019)

First Author: Ratnasothy K

Attributed to: USE OF LOW-DOSE IL-2 TO EXPAND ENDOGENOUS REGULATORY T CELLS AND ACHIEVE TRANSPLANTATION TOLERANCE funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/ajt.15306

PubMed Identifier: 30748096

Publication URI: http://europepmc.org/abstract/MED/30748096

Type: Journal Article/Review

Volume: 19

Parent Publication: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Issue: 7

ISSN: 1600-6135